Adult triclabendazole-resistant Fasciola hepatica: Morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model

Journal of Helminthology

Volumn 83, Issue 2, 2009, Pages 151-163

  O'Neill, J F ^a   Johnston, R C ^a   Halferty, L ^a   Brennan, G P ^a   Keiser, J ^b   Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; TRICLABENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FASCIOLA HEPATICA; FASCIOLIASIS; IN VIVO STUDY; INTEGUMENT; INTESTINE; MALE; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SYNCYTIUM; TRANSMISSION ELECTRON MICROSCOPY;

FASCIOLA HEPATICA; RATTUS;

EID: 70350564867     PISSN: 0022149X     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0022149X09344934     Document Type: Article

References (63)

1. Alvarez-Sánchez, M.A., Mainar-Jaime, R.C., Pérez- García, J. & Rojo-Vázquez, F.A. (2006) Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain. Veterinary Record 159, 424-425.
2. Bennett, C.E. (1975) Scanning electron microscopy of Fasciola hepatica during migration in the mouse. Journal of Parasitology 61, 892-898.
3. Berman, P.A. & Adams, P.A. (1997) Artemisinin enhances heme-catalysed oxidation of lipid membranes. Free Radical Biology and Medicine 22, 1283-1288.
4. Boray, J.C. (1994) Disease of domestic animals caused by flukes. 49 pp. Rome, Food and Agricultural Organization of the United Nations.
5. Boray, J.C., Crowfoot, P.D., Strong, M.B., Allison, J.R., Schellenbaum, M., Von Orelli, M. & Sarasin, G. (1983) Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Veterinary Record 113, 315-317.
6. Coles, G.C. & Stafford, K.A. (2001) Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. Veterinary Record 148, 723-724.
7. Coles, G.C., Rhodes, A.C. & Stafford, K.A. (2000) The activity of closantel against adult triclabendazoleresistant Fasciola hepatica. Veterinary Record 146, 504.
8. Dubin, M. & Stoppani, A.O.M. (2000) Programmed cell death and apoptosis. The role of mitochondria. Medicina-Buenosa Aires 60, 375-386.
9. Eckstein-Ludwig, U.,Webb, R., van Goethem, I., East, J., Lee, A., Kimura, M., O'Neill, P., Bray, P., Ward, S. & Krishna, S. (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424, 957-961.
10. Fairweather, I. (2005) Triclabendazole: new skills to unravel an old(ish) enigma. Journal of Helminthology 79, 227-234.
11. Fairweather, I. (2009) Triclabendazole progress report, 2005-2009: an advancement of learning? Journal of Helminthology.
12. Fairweather, I., Threadgold, L.T. & Hanna, R.E.B. (1999) Development of Fasciola hepatica in the mammalian host. pp. 47-111 in Dalton, J.P. (Ed.) Fasciolosis. Wallingford, Oxon, CAB International.
13. Halferty, L., Brennan, G.P., Hanna, R.E.B., Edgar, H.W., Meaney, M., McConville, M., Trudgett, A., Hoey, L. & Fairweather, I. (2008) Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole. Veterinary Parasitology 155, 49-58.
14. Hien, T.T., Truong, N.G., Minh, N.H., Dat, H.D., Dung, N.T., Hue, N.T., Dung, T.K., Tuan, P.Q., Campbell, J.I., Farrar, J.J. & Day, J.N. (2008) A randomised controlled pilot study of artesunate versus triclabendazole for human fascioliasis in Central Vietnam. American Journal of Tropical Medicine and Hygiene 78, 388-392.
15. Jung, J., Kim, H., Nam, K.Y. & No, K.T. (2005) Three-dimensional structure of Plasmodium falciparum Ca-ATPase (PfATP6) and docking of artemisinin derivatives to PfATP6. Bioorganic and Medicinal Chemistry Letters 15, 2994-2997.
16. Keiser, J. & Utzinger, J. (2007) Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Current Opinion in Infectious Diseases 20, 605-612.
17. Keiser, J. & Morson, G. (2008a) Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether. Experimental Parasitology 118, 228-237.
18. Keiser, J. & Morson, G. (2008b) Fasciola hepatica: surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78. Experimental Parasitology 119, 87-93.
19. Keiser, J., Engels, D., Büscher, G. & Utzinger, J. (2005) Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opinion in Investigational Drugs 14, 1513-1526.
20. Keiser, J., Xiao, S.H., Xue, J., Chang, Z.S., Odermatt, P., Tesana, S., Tanner, M. & Utzinger, J. (2006a) Effect of artesunate and artemether against Clonorchis sinensis and Opisthorchis viverrini in rodent models. International Journal of Antimicrobial Agents 28, 370-373.
21. Keiser, J., Xiao, S.H., Tanner, M. & Utzinger, J. (2006b) Artesunate and artemether are effective fasciolicides in the rat model and in vitro. Journal of Antimicrobial Chemotherapy 57, 1139-1145.
22. Keiser, J., Utzinger, J., Tanner, M., Dong, Y. & Vennerstrom, J.L. (2006c) The synthetic peroxide OZ78 is effective against Echinostoma caproni andFasciola hepatica. Journal of Antimicrobial Chemotherapy 58, 1193-1197.
23. Keiser, J., Utzinger, J., Vennerstrom, J.L., Dong, Y., Brennan, G. & Fairweather, I. (2007a) Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica. Transactions of the Royal Society for Tropical Medicine and Hygiene 101, 1219-1222.
24. Keiser, J., Xiao, S.H., Dong, Y., Utzinger, J. & Vennerstrom, J.L. (2007b) Clonorchicidal properties of the synthetic trioxolane OZ78. Journal of Parasitology 93, 1209-1214.
25. Keiser, J., Rinaldi, L., Veneziano, V., Mezzino, L., Tanner, M., Utzinger, J. & Cringoli, G. (2008) Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep. Parasitology Research 103, 517-522.
26. Lefèvre, G. & Thomsen, M.S. (1999) Clinical pharmacokinetics of artemether and lumefantrine (Riametw). Clinical Drug Investigation 18, 467-480.
27. Li, Q.-G., Peggins, J.O., Fleckenstein, L.L., Masonic, K., Heiffer, M.H. & Brewer, T.G. (1998) The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. Journal of Pharmacy and Pharmacology 50, 173-182.
28. Li, W., Mo, W., Shen, D., Sun, L., Wang, J., Lu, S., Gitschier, J.M. & Zhou, B. (2005) Yeast model uncovers dual roles of mitochondria in the action of artemisinin. PloS Genetics 1, 329-334.
29. Mas-Coma, S., Bargues, M.D. & Valero, M.A. (2005) Fascioliasis and other plant-borne trematode zoonoses. International Journal for Parasitology 35, 1255-1278.
30. Mason, R.P., Walter, M.F. & Mason, P.E. (1997) Effect of oxidative stress on membrane structure: small-angle X-ray diffraction analysis. Free Radical Biology and Medicine 23, 419-425.
31. McConville, M., Brennan, G.P., Flanagan, A., Edgar, H.W.J., McCoy, M., Castillo, R., Hernández-Campos, A. & Fairweather, I. (2008) Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Veterinary Parasitology 153, 52-64.
32. McConville, M., Brennan, G.P., Flanagan, A., Edgar, H.W.J., Hanna, R.E.B., McCoy, M., Gordon, A.W., Castillo, R.C., Hernández-Campos, A. & Fairweather, I. (2009a) An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica. Veterinary Parasitology (in press).
33. McConville, M., Brennan, G.P., Flanagan, A., Edgar, H.W.J., Castillo, R., Hernández-Campos, A. & Fairweather, I. (2009b) Ultrastructural changes to the tegumental system and the gastrodermal cells in mature flukes following in vivo treatment with the experimental fasciolicide, compound alpha. Parasitology (in press).
34. McCoy, M.A., Fairweather, I., Brennan, G.P., Kenny, J.M. & Forbes, A.B. (2005) The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabendazole-resistant Fasciola hepatica in sheep. Research in Veterinary Sciences 78, 33.
35. McKinstry, B., Fairweather, I., Brennan, G.P. & Forbes, A.B. (2003) Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax). Parasitology Research 91, 251-263.
36. McKinstry, B., Brennan, G.P., Halferty, L., Forbes, A.B. & Fairweather, I. (2007) Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax). Parasitology Research 101, 929-941.
37. McKinstry, B.,Halferty, L., Brennan,G.P.&Fairweather, I. (2009) Morphological response of triclabendazolesusceptible and triclabendazole- resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax). Parasitology Research 104, 645-655.
38. Meaney, M., Fairweather, I., Brennan, G.P., McDowell, L.S.L. & Forbes, A.B. (2003) Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes. Parasitology Research 91, 238-250.
39. Meaney, M., Haughey, S., Brennan, G.P. & Fairweather, I. (2005a) A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica. Parasitology Research 95, 117-128.
40. Meaney, M., Haughey, S., Brennan, G.P. & Fairweather, I. (2005b) A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica. Parasitology Research 96, 189-198.
41. Meaney, M., Haughey, S., Brennan, G.P. & Fairweather, I. (2005c) Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica. Parasitology Research 95, 201-212.
42. Meaney, M., Allister, J., McKinstry, B., McLaughlin, K., Brennan, G.P., Forbes, A.B. & Fairweather, I. (2006) Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitology Research 99, 609-621.
43. Mitchell, G.B.B. (2002) Update on fasciolosis in cattle and sheep. In Practice 24, 378-385.
44. Mottier, L., Alvarez, L., Fairweather, I. & Lanusse, C. (2006a) Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. Journal of Parasitology 92, 1355-1360.
45. Mottier, L., Alvarez, L., Ceballos, L. & Lanusse, C. (2006b) Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics. Experimental Parasitology 113, 49-57.
46. Navaratnam, V., Mansor, S.M., Sit, N.W., Grace, J., Li, Q. & Olliaro, P. (2000) Pharmacokinetics of artemisinintype compounds. Clinical Pharmacokinetics 39, 255-266.
47. Overend, D.J. & Bowen, F.L. (1995) Resistance of Fasciola hepatica to triclabendazole. Australian Veterinary Journal 72, 275-276.
48. Robinson, G. & Threadgold, L.T. (1975) Electron microscope studies of Fasciola hepatica. XII. The fine structure of the gastrodermis. Experimental Parasitology 37, 20-36.
49. Robinson, M.W., Trudgett, A., Hoey, E.M. & Fairweather, I. (2002) Triclabendazole-resistant Fasciola hepatica: b-tubulin and response to in vitro treatment with triclabendazole. Parasitology 124, 325-338.
50. +-pump ATPase by iron-generated free radicals. Protection by 6,7-dimethyl-2,4-di-1-pyrrolidinyl- 7Hpyrrol0[ 2,3-d]pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger. Biochemical Pharmacology 51, 471-476.
51. Skuce, P.J. & Fairweather, I. (1990) The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica. Parasitology Research 76, 241-250.
52. Sumegi, B., Kovacs, K., Veres, B., Radnai, B., Varbiro, G., Bognar, Z., Toth, A. & Gallyas, F. (2005) Oxidative stress and the endoplasmic reticulum. pp. 121-130 in Benedetti, A., Banhegyi, G. & Burchell, A. (Eds) Endoplasmic reticulum: a metabolic compartment (NATO Science Series, Vol. 363). Amsterdam, IOS Press.
53. Threadgold, L.T. (1963) The tegument and associated structures of Fasciola hepatica. Quarterly Journal of the Microscopical Society 104, 505-512.
54. Threadgold, L.T. (1967) Electron-microscope studies of Fasciola hepatica. III. Further observations on the tegument and associated structures. Parasitology 57, 633-637.
55. Toner, E., McConvery, F., Brennan, G.P., Meaney, M. & Fairweather, I. (2009) A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Parasitology (in press).
56. Uhlemann, A.-C., Wittlin, S., Matile, H., Bustamante, L.Y. & Krishna, S. (2007) Mechanism of antimalarial action of the synthetic trioxolane RBX1160 (OZ277). Antimicrobial Agents and Chemotherapy 51, 667-672.
57. Utzinger, J., Xiao, S.-H., Tanner, M. & Keiser, J. (2007) Artemisinins for schistosomiasis and beyond. Current Opinion in Investigational Drugs 8, 105-116.
58. Wakabayashi, T. & Karbowski, M. (2001) Structural changes of mitochondria related to apoptosis. Biological Signals and Receptors 10, 26-56.
59. Walker, S., McKinstry, B., Boray, J.C., Brennan, G.P., Trudgett, A., Hoey, E.M., Fletcher,H.&Fairweather, I. (2004) Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro. Parasitology Research 94, 427-438.
60. WHO (2007) Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control, held at WHO Headquarters, Geneva, Switzerland, October 2006. 33 pp.
61. Wolstenholme, A., Fairweather, I., Prichard, R., Von Samson- Himmelstjerna, G. & Sangster, N. (2004) Drug resistance in veterinary helminths. Trends in Parasitology 20, 469-476.
62. Woodrow, C., Haynes, R. & Krishna, S. (2005) Artemisinins. Postgraduate Medical Journal 81, 71-78.
63. Xiao, S.-H.,Wu, Y.-L., Tanner,M.,Wu,W.-M., Utzinger, J., Mei, J.-Y., Scorneaux, B., Chollet, J. & Zhai, Z. (2003) Schistosoma japonicum: in vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media. Parasitology Research 89, 459-466.